Brown S L, Cherry M G, Fisher P, Hope-Stone L. Hussain R N, Heimann H & Damato B (2020 ) Predictors of Long-term Anxiety and Depression in Uveal Melanoma Survivors: A Cross-lagged Five-year Analysis Psycho-Oncology https:// doi .1002/pon.5514 (in press)
Hope-Stone, L., Brown, S. L., Heimann, H., Damato, B (2019) Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: A two-year cohort study. Eye: doi.org 10.1038/s41433-019-0440-0 published online 15th April 2019
Damato, B., Hope-Stone, L., Cooper, B., Brown, S., Salmon, P., Heimann, H., & Dunn, L (2019) Patient-Reported Outcomes and Quality of Life after Treatment for Choroidal Melanoma. Ocular Oncology & Pathology doi: 10.1159/000496927
Hope-Stone , L., Ablett,J., Salmon, P (2018) Reflections on a Health Psychology Service for Patients with Uveal Melanoma: The Challenge of Psychological Screening and Intervention when Distress is ‘Normal’ Journal of Clinical Psychology in Medical Settings doi-org.liverpool.idm.oclc.org/s10880-018-9595-2
Brown, S.L. Hope-Stone, L., Heimann, H., Damato, B. Salmon, P. (2018) Predictors of anxiety and depression 2 years following treatment in uveal melanoma survivors Psycho-Oncology 27, (7) 1727-1734
Damato, B., Hope-Stone, L., Cooper, B., Brown, S.L., Salmon, P., Heimann, H., Dunn, L.B.(2018) Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients American Journal of Ophthalmology 193, 230-251
Hope-Stone, L. Brown, S.. Heimann, H. Damato, B. Salmon, P, et al. (2016). Two-year patient-reported outcomes following treatment of uveal melanoma. Eye 30(12): 1598-1605.
Hope-Stone L, and Brown, SL (2016) “Phantom eye syndrome in uveal melanoma” Optometry Today 56(9), 80-83.
Hope-Stone, L., Brown, S.L., Heimann, H., Damato, B., Salmon, P. (2015). "How do patients with uveal melanoma experience and manage uncertainty? A qualitative study." Psycho-Oncology 24(11): 1485-1491.
Hope-Stone, L., Brown, S.L. Heimann, H. Damato, B. Salmon, P., et al. (2015). Phantom eye syndrome: Patient experiences after enucleation for uveal melanoma. Ophthalmology 122(8): 1585-1590.
Hope-Stone, L. and B. Damato (2014). Counseling patients with cancer. Clinical Ophthalmic Oncology: Basic Principles and Diagnostic Techniques. A. Singh and B. Damato: 133-140.
Sandinha, T., Hebbar, G., Kenawy, N., Hope-Stone, L., & Damato, B. (2012). A nurse-led ocular oncology clinic in Liverpool: results of a 6-month trial. Eye, 26(7), 937.
Francis, R. J., Sharma, S. K., Springer, C., Green, A. J., Hope-Stone, L. D., Sena, L., ... & O'malley, D. (2002). A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer, 87(6), 600-607.
Hope-Stone, L. D., & Mills, B. J. (2001). Developing empathy to improve patient care: A pilot study of cancer nurses. International Journal of Palliative Nursing, 7(3), 146-150.
Hope-Stone, L.D (1997) The benefits of quality of life measurement in patient care--Part II: A case study European Journal of Cancer Care 6 (4) 23-24
Hope-Stone, L.D., Napier, M.P., Begent, R.H., Cushen, N., O'Malley, D. (1997) The importance of measuring quality of life in phase I/II trials of cancer therapy--the effects of antibody targeted therapy: Part I European Journal of Cancer Care 6 (94) 267-272
Begent, R.H.J. Verhaar, M.J. Chester, K.A. Casey, J.L., Green, A.J. Napier, M.P. Hope-Stone, L.D., Cushen, N., Keep, P.A., Johnson, C.J. Hawkins, R.E., Hilson, A.J.W., Robson, L. (1996) Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library Nature Medicine 2 (9) 979-94
Lane, D. M., Eagle, K. F., Begent, R. H. J., Hope-Stone, L. D., Green, A. J., Casey, J. L., ... & Glaser, M. G. (1994). Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F (ab') 2 antibodies. British Journal of Cancer, 70(3), 521-525.
